Liminatus Pharma

(NASDAQ) LIMN

Current Price$0.21

Market Cap$9.21M

Since IPO (2021)-98%

5 YearN/A

1 Year-98%

1 Month+20%

Liminatus Pharma Financials at a Glance

Market Cap

$9.21M

Revenue (TTM)

$0.00

Net Income (TTM)

$9.88M

EPS (TTM)

$-0.36

P/E Ratio

-0.56

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Price

$0.21

Volume

1,600

Open

$0.21

Price

$0.21

Volume

1,600

Open

$0.21

Previous Close

$0.21

Daily Range

$0.21 - $0.21

52-Week Range

$0.16 - $33.66

Dividend

$0.00

Beta (Volatility)

1.10 (Average)

Price

$0.21

Volume

1,600

Open

$0.21

Previous Close

$0.21

Daily Range

$0.21 - $0.21

52-Week Range

$0.16 - $33.66

LIMN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Liminatus Pharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Chris Kim

Website

liminatuspharma.com

Headquarters

La Palma, CA 90623, US

LIMN Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

28%

Return on Assets

-19%

Earnings Yield

-1.79%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.21M

Shares Outstanding

44.88M

Volume

1.60K

Avg. Volume

11.26M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$2.97M

EBITDA

$9.99M

Operating Cash Flow

$9.96M

Capital Expenditure

$13.11K

Free Cash Flow

$9.98M

Cash & ST Invst.

$337.65K

Total Debt

$1.44M

Liminatus Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$9.21M

N/A

Market Cap/Employee

$3.07M

N/A

Employees

N/A

Net Income

$8.17M

-840.8%

EBITDA

$8.15M

-1018.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$1.10M

+74.4%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$1.44M

-71.8%

Return on Assets

-19.27%

N/A

Return on Invested Capital

27.63%

N/A

Free Cash Flow

$386.85K

+50.8%

Operating Cash Flow

$386.85K

+50.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

JSPRJasper Therapeutics, Inc.

JSPRJasper Therapeutics, Inc.$0.99+5.99%

DYAIDyadic International, Inc.

DYAIDyadic International, Inc.$0.76-3.29%

EVAXEvaxion Biotech A/S

EVAXEvaxion Biotech A/S$4.52+0.56%

BTAIBioXcel Therapeutics, Inc.

BTAIBioXcel Therapeutics, Inc.$1.24+2.92%

SABSSAB Biotherapeutics, Inc.

SABSSAB Biotherapeutics, Inc.$3.54+1.90%

MURAMural Oncology plc

MURAMural Oncology plc$2.04+0.00%

GBIOGeneration Bio Co.

GBIOGeneration Bio Co.$5.34+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$8.58+2.71%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.86-0.02%

NCLHNorwegian Cruise Line

NCLHNorwegian Cruise Line$17.30-0.08%

ONDSOndas

ONDSOndas$9.81-0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.85+0.03%

ADTADT

ADTADT$7.11-0.06%

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF$9.09+0.13%

Questions About LIMN

What is the current price of Liminatus Pharma?

Liminatus Pharma is trading at $0.21 per share.

What is the 52-week range for Liminatus Pharma?

Over the past 52 weeks, Liminatus Pharma has traded between $0.16 and $33.66.

How much debt does Liminatus Pharma have?

As of the most recent reporting period, Liminatus Pharma reported total debt of $1.44M.

How much cash does Liminatus Pharma have on hand?

Liminatus Pharma reported $337,655 in cash and cash equivalents in its most recent financial results.

What is Liminatus Pharma’s dividend yield?

Liminatus Pharma does not currently have a dividend yield.

Liminatus Pharma

Liminatus Pharma Financials at a Glance

LIMN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Liminatus Pharma

LIMN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Liminatus Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LIMN

What is the current price of Liminatus Pharma?

What is the 52-week range for Liminatus Pharma?

How much debt does Liminatus Pharma have?

How much cash does Liminatus Pharma have on hand?

What is Liminatus Pharma’s dividend yield?

Premium Investing Services